Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

735 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-life evaluation of clinical outcomes in patients undergoing treatment for non-tuberculous mycobacteria lung disease: A ten-year cohort study.
Aliberti S, Sotgiu G, Castellotti P, Ferrarese M, Pancini L, Pasat A, Vanoni N, Spotti M, Mazzola E, Gramegna A, Saderi L, Perno CF, van Ingen J, Codecasa LR, Blasi F. Aliberti S, et al. Among authors: perno cf. Respir Med. 2020 Apr;164:105899. doi: 10.1016/j.rmed.2020.105899. Epub 2020 Feb 14. Respir Med. 2020. PMID: 32094101 Free article.
Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods study.
Villa S, Codecasa LR, Faccini M, Pontello MM, Ferrarese M, Castellotti PF, Senatore S, Lamberti A, Mazzola E, Perno CF, Campisi D, Saporiti M, Raviglione MC. Villa S, et al. Among authors: perno cf. Eur Respir J. 2020 Apr 30;55(4):2000052. doi: 10.1183/13993003.00052-2020. Print 2020 Apr. Eur Respir J. 2020. PMID: 32354859 Free article. No abstract available.
Prolongation of incubation time improves clinical diagnosis of Mycobacterium xenopi infection and allows susceptibility testing of mycobacterial strains against multiple antibiotics.
Cento V, Nava A, Lepera V, Torri S, Colagrossi L, Fanti D, Vismara C, Perno CF, Mazzola E. Cento V, et al. Among authors: perno cf. J Glob Antimicrob Resist. 2020 Sep;22:533-537. doi: 10.1016/j.jgar.2020.04.028. Epub 2020 May 5. J Glob Antimicrob Resist. 2020. PMID: 32387259 Free article.
Rapid Detection and Quantification of Mycobacterium tuberculosis DNA in Paraffinized Samples by Droplet Digital PCR: A Preliminary Study.
Antonello M, Scutari R, Lauricella C, Renica S, Motta V, Torri S, Russo C, Gentile L, Cento V, Colagrossi L, Mattana G, Codecasa LR, Vismara C, Scaglione F, Veronese SM, Bonoldi E, Bandera A, Gori A, Mazzola E, Perno CF, Alteri C. Antonello M, et al. Among authors: perno cf. Front Microbiol. 2021 Sep 13;12:727774. doi: 10.3389/fmicb.2021.727774. eCollection 2021. Front Microbiol. 2021. PMID: 34589075 Free PMC article.
Real life experiences in HCV management in 2018.
Viganò M, Andreoni M, Perno CF, Craxì A, Aghemo A, Alberti A, Andreone P, Babudieri S, Bonora S, Brunetto MR, Bruno R, Bruno S, Calvaruso V, Caporaso N, Cartabellotta F, Ceccherini-Silberstein F, Cento V, Ciancio A, Colombatto P, Coppola N, Di Marco V, Di Perri G, Fagiuoli S, Gaeta GB, Gasbarrini A, Lampertico P, Pellicelli A, Prestileo T, Puoti M, Raimondo G, Rizzardini G, Taliani G, Zignego AL. Viganò M, et al. Among authors: perno cf. Expert Rev Anti Infect Ther. 2019 Feb;17(2):117-128. doi: 10.1080/14787210.2019.1563755. Epub 2019 Jan 15. Expert Rev Anti Infect Ther. 2019. PMID: 30582384 Free article. Review.
Large community-acquired Legionnaires' disease outbreak caused by Legionella pneumophila serogroup 1, Italy, July to August 2018.
Faccini M, Russo AG, Bonini M, Tunesi S, Murtas R, Sandrini M, Senatore S, Lamberti A, Ciconali G, Cammarata S, Barrese E, Ceriotti V, Vitaliti S, Foti M, Gentili G, Graziano E, Panciroli E, Bosio M, Gramegna M, Cereda D, Perno CF, Mazzola E, Campisi D, Aulicino G, Castaldi S, Girolamo A, Caporali MG, Scaturro M, Rota MC, Ricci ML. Faccini M, et al. Among authors: perno cf. Euro Surveill. 2020 May;25(20):1900523. doi: 10.2807/1560-7917.ES.2020.25.20.1900523. Euro Surveill. 2020. PMID: 32458793 Free PMC article.
Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis.
Rossotti R, Travi G, Ughi N, Corradin M, Baiguera C, Fumagalli R, Bottiroli M, Mondino M, Merli M, Bellone A, Basile A, Ruggeri R, Colombo F, Moreno M, Pastori S, Perno CF, Tarsia P, Epis OM, Puoti M; Niguarda COVID-19 Working Group. Rossotti R, et al. Among authors: perno cf. J Infect. 2020 Oct;81(4):e11-e17. doi: 10.1016/j.jinf.2020.07.008. Epub 2020 Jul 8. J Infect. 2020. PMID: 32652164 Free PMC article.
735 results